Comparison between thromboelastography and conventional coagulation assays in patients with deep vein thrombosis

Chaoqin Mao1, Yueshan Xiong2, Cheng Fan3

  • 1Department of Rehabilitation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Insights

Thromboelastography (TEG) effectively identifies deep vein thrombosis (DVT) and hypercoagulability, outperforming conventional coagulation assays (CCAs). TEG offers superior insights into DVT patient coagulation status compared to CCAs.

Area of Science:

  • Hematology
  • Vascular Medicine
  • Diagnostic Imaging

Background:

  • Conventional coagulation assays (CCAs) have limitations in assessing coagulation in deep vein thrombosis (DVT) patients.
  • There is a need for more effective methods to evaluate coagulation status in DVT.
  • Thromboelastography (TEG) is a potential alternative for DVT assessment.

Purpose of the Study:

  • To compare the efficacy of TEG and CCAs in identifying DVT.
  • To evaluate coagulation status in DVT patients using both TEG and CCAs.
  • To determine the diagnostic capabilities of TEG versus CCAs for DVT.

Main Methods:

  • A study involving 66 DVT patients and 40 healthy controls.
  • Blood samples analyzed using TEG and CCAs within 4 hours of hospital admission.
  • Comparative analysis of TEG and CCA parameters between DVT patients and controls.

Main Results:

  • TEG revealed significant differences, indicating hypercoagulability in DVT patients.
  • CCAs showed no significant differences between DVT patients and controls.
  • TEG demonstrated a superior ability to identify DVT compared to CCAs.
  • Few correlations were found between TEG and CCA parameters.

Conclusions:

  • TEG is advantageous for identifying DVT and detecting hypercoagulability.
  • TEG provides a better understanding of coagulation status in DVT patients than CCAs.
  • TEG offers a more insightful diagnostic approach for DVT management.
Abstract

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
85
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
82
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
89
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
641